Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Tsuyuki

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
European Heart Journal|January 1, 1996
Using exercise endpoints in heart failure trials: design considerationsS Yusuf, R Tsuyuki
Hospital Quarterly|May 27, 1999
Improving women's health quality: the value of closing the care gapT Montague, R Tsuyuki, K Teo
Pregnancy Hypertension|June 25, 2015
OS104. Are preeclampsia and adverse obstetrical outcomes predictors for longterm cardiovascular disease?W W Sia, R Tsuyuki, S Pertman, et al.
Chest|March 1, 1994
Prevention and regression of coronary atherosclerosis. Is it safe and efficacious therapy?T Montague, R Tsuyuki, J Burton, et al.
Lancet (London, England)|January 11, 2002
Blood-pressure reduction and cardiovascular risk in HOPE studyP Sleight, S Yusuf, J Pogue, et al.
Psychopharmacology|August 14, 2017
Decreased serum L-arginine and L-citrulline levels in major depressionS Hess, G Baker, G Gyenes, et al.
The Canadian Journal of Cardiology|June 1, 1995
Can practice patterns and outcomes be successfully altered? Examples from cardiovascular medicine. The Clinical Quality Improvement Network (CQIN) InvestigatorsT Montague, L Taylor, S Martin, et al.
European Heart Journal|August 23, 2000
Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failureN Suskin, R S McKelvie, R J Burns, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|August 16, 2000
Bioequivalence and interchangeability of narrow therapeutic range drugs. Canadian Society for Pharmaceutical Sciences discussionE Palylyk-Colwell, F Jamali, W Dryden, et al.
The Canadian Journal of Cardiology|January 5, 2002
The 2001 Canadian Cardiovascular Society consensus guideline update for the management and prevention of heart failureP Liu, M Arnold, I Belenkie, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
European Heart Journal|January 1, 1996
Using exercise endpoints in heart failure trials: design considerationsS Yusuf, R Tsuyuki
Hospital Quarterly|May 27, 1999
Improving women's health quality: the value of closing the care gapT Montague, R Tsuyuki, K Teo
Pregnancy Hypertension|June 25, 2015
OS104. Are preeclampsia and adverse obstetrical outcomes predictors for longterm cardiovascular disease?W W Sia, R Tsuyuki, S Pertman, et al.
Chest|March 1, 1994
Prevention and regression of coronary atherosclerosis. Is it safe and efficacious therapy?T Montague, R Tsuyuki, J Burton, et al.
Lancet (London, England)|January 11, 2002
Blood-pressure reduction and cardiovascular risk in HOPE studyP Sleight, S Yusuf, J Pogue, et al.
Psychopharmacology|August 14, 2017
Decreased serum L-arginine and L-citrulline levels in major depressionS Hess, G Baker, G Gyenes, et al.
The Canadian Journal of Cardiology|June 1, 1995
Can practice patterns and outcomes be successfully altered? Examples from cardiovascular medicine. The Clinical Quality Improvement Network (CQIN) InvestigatorsT Montague, L Taylor, S Martin, et al.
European Heart Journal|August 23, 2000
Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failureN Suskin, R S McKelvie, R J Burns, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|August 16, 2000
Bioequivalence and interchangeability of narrow therapeutic range drugs. Canadian Society for Pharmaceutical Sciences discussionE Palylyk-Colwell, F Jamali, W Dryden, et al.
The Canadian Journal of Cardiology|January 5, 2002
The 2001 Canadian Cardiovascular Society consensus guideline update for the management and prevention of heart failureP Liu, M Arnold, I Belenkie, et al.
Pageof 2